Abstract
Domestic and international regulation of smokeless tobacco (ST) products is now possible through statutory and regulatory codes and international treaties. In spite of the improved regulatory climate, efforts directed specifically at ST have not been pursued with the zeal that has characterized the regulation of cigarettes. This chapter focuses on the legislation that enables authority to regulate ST, the challenges of regulation presented by ST products, and some key knowledge gaps and research needs that may push forward scientific-based regulation. Although there is an acknowledged demonstrable public health risk from ST use, that risk is certainly less than from cigarettes and other combustible tobacco products. Because ST products are less harmful, some may consider their use a form of harm reduction in the overall risk assessment of tobacco usage. Issues in that controversy are addressed.
Original language | English (US) |
---|---|
Title of host publication | Smokeless Tobacco Products |
Subtitle of host publication | Characteristics, Usage, Health Effects, and Regulatory Implications |
Publisher | Elsevier |
Pages | 189-209 |
Number of pages | 21 |
ISBN (Electronic) | 9780128181591 |
ISBN (Print) | 9780128181584 |
DOIs | |
State | Published - Jan 21 2020 |
Externally published | Yes |
Keywords
- 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK)
- Modified risk tobacco products
- N-nitrosonornicotine (NNN)
- Public health effects of smokeless tobacco
- Smokeless tobacco
- Snuff
- Snus
- Tobacco regulation
- Tobacco-specific nitrosamines (TSNA)
- World Health Organization Framework Convention on Tobacco Control (FCTC)
ASJC Scopus subject areas
- General Chemistry